Candida glabrata and FKS mutations: Witnessing the emergence of the true multidrug-resistant Candida

Clinical Infectious Diseases

Volumn 56, Issue 12, 2013, Pages 1733-1734

  Ostrosky Zeichner, Luis ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Candida glabrata; echinocandins; FKS mutation; multidrug resistant Candida

Indexed keywords

ECHINOCANDIN; FLUCONAZOLE; POLYENE;

ANTIFUNGAL SUSCEPTIBILITY; CANDIDA GLABRATA; END STAGE LIVER DISEASE; HUMAN; INTENSIVE CARE UNIT; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIDRUG RESISTANT CANDIDA; MUTATION; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

CANDIDA GLABRATA; ECHINOCANDINS; FKS MUTATION; MULTIDRUG-RESISTANT CANDIDA;

ANTIFUNGAL AGENTS; CANDIDA GLABRATA; CANDIDIASIS; ECHINOCANDINS; FEMALE; FUNGAL PROTEINS; HUMANS; MALE;

EID: 84878319377     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit140     Document Type: Note

References (18)

1. Pfaller MA, Diekema DJ, Gibbs DL, et al. Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J Clin Microbiol 2008; 46:515-21.
2. Moudgal V, Little T, Boikov D, Vazquez JA. Multiechinocandin-and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis. Antimicrob Agents Chemother 2005; 49:767-9.
3. Prasad R, Kapoor K. Multidrug resistance in yeast Candida. Int Rev Cytol 2005; 242:215-48.
4. Ostyn B, Noe A, Swinne D, Ieven M, Colebunders R. A multidrug, including voricona-zole, resistant oral Candida infection in an AIDS patient effectively treated with echino-candin. J Infect 2002; 44:57-8.
5. Dessy LA, Corrias F, Marchetti F, et al. Implant infection after augmentation mammaplasty: a review of the literature and report of a multidrug-resistant Candida albi-cans infection. Aesthetic Plast Surg 2012; 36:153-9.
6. Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole anti-fungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int J Antimicrob Agents 2011; 38: 65-9.
7. Cleveland AA, Farley MM, Harrison LH, et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 2012; 55:1352-61.
8. Perlin DS. Resistance to echinocandin-class antifungal drugs. Drug Resist Updat 2007; 10:121-30.
9. Kurtz MB, Abruzzo G, Flattery A, et al. Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies. Infect Immun 1996; 64:3244-51.
10. Douglas CM, Marrinan JA, Li W, Kurtz MB. A Saccharomyces cerevisiae mutant with echinocandin-resistant 1, 3-beta-D-glucan synthase. J Bacteriol 1994; 176:5686-96.
11. Shields RK, Nguyen MH, Press EG, et al. The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata. Antimicrob Agents Chemother 2012; 56:4862-9.
12. Alexander BD, Johnson MD, Pfeiffer CD, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations [published online ahead of print 13 March 2013]. Clin Infect Dis 2013; 56: 1724-32.
13. Arendrup MC, Perlin DS, Jensen RH, Howard SJ, Goodwin J, Hope W. Differential in vivo activities of anidulafungin, caspofun-gin, and micafungin against Candida glabra-ta isolates with and without FKS resistance mutations. Antimicrob Agents Chemother 2012; 56:2435-42.
14. Chapeland-Leclerc F, Hennequin C, Papon N, et al. Acquisition of flucytosine, azole, and caspofungin resistance in Candida glab-rata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient. Antimicrob Agents Chemother 2010; 54:1360-2.
15. Khan ZU, Ahmad S, Al-Obaid I, Al-Sweih NA, Joseph L, Farhat D. Emergence of resistance to amphotericin B and triazoles in Candida glabrata vaginal isolates in a case of recurrent vaginitis. J Chemother 2008; 20: 488-91.
16. Krogh-Madsen M, Arendrup MC, Heslet L, Knudsen JD. Amphotericin B and caspofun-gin resistance in Candida glabrata isolates recovered from a critically ill patient. Clin Infect Dis 2006; 42:938-44.
17. Sterling TR, Gasser RA Jr, Ziegler A. Emergence of resistance to amphotericin B during therapy for Candida glabrata infection in an immunocompetent host. Clin Infect Dis 1996; 23:187-8.
18. Warnock DW, Burke J, Cope NJ, Johnson EM, von Fraunhofer NA, Williams EW. Flu-conazole resistance in Candida glabrata. Lancet 1988; 2:1310.